Drug Chatter -- Tracking biopharma stock chatter

Profile for Lipocine Inc. (LPCN)

« Back to company index

LPCN Chatter Timeline

Stock Ticker for LPCN

Most Active Tweeters for LPCN

UserTweets
@keitrader 4
@GNWLive 3
@stockboardinc 3
@confcalltran 3
@vanjohn10 3

Recent Tweets for LPCN

TheMarketsDaily @TheMarketsDaily
Somewhat Positive News Coverage Somewhat Unlikely to Impact Lipocine $LPCN Share Price https://t.co/VrOZandxAg
September 25th 2017, 5:09pm
PiggyBankPeople @PiggyBankPeople
RT @ZacksAwareness: Patent Board Motions Decision a Positive https://t.co/HS13tEFw54 $LPCN @vanjohn10 #biotech https://t.co/vI5YpBOjki
September 25th 2017, 1:09pm
InstitutionalZC @InstitutionalZC
Patent Board Motions Decision a Positive https://t.co/xM5AkghzD4 $LPCN @vanjohn10 #biotech https://t.co/KsOQ8O8zhs
September 25th 2017, 12:09pm
ahighelevation @ahighelevation
Patent Board Motions Decision a Positive https://t.co/nOUfAo6bj0 $LPCN @vanjohn10 #biotech https://t.co/t4Rx45whCC
September 25th 2017, 12:09pm
ZacksAwareness @ZacksAwareness
Patent Board Motions Decision a Positive https://t.co/HS13tEFw54 $LPCN @vanjohn10 #biotech https://t.co/vI5YpBOjki
September 25th 2017, 12:09pm
RoboSchmobo @RoboSchmobo
RT @VCapital_invest: Patent Board Motions Decision a Positive $LPCN @vanjohn10 #biotech https://t.co/pYyQZ62Prj https://t.co/mP0Lv5bT1m
September 25th 2017, 12:09pm
cmiller1225 @cmiller1225
RT @tzack16: Patent Board Motions Decision a Positive https://t.co/qALWcjuA5V $LPCN @vanjohn10 #biotech https://t.co/PWBoPeR53w
September 25th 2017, 12:09pm
tzack16 @tzack16
Patent Board Motions Decision a Positive https://t.co/qALWcjuA5V $LPCN @vanjohn10 #biotech https://t.co/PWBoPeR53w
September 25th 2017, 12:09pm
zackcappsocial @zackcappsocial
Patent Board Motions Decision a Positive https://t.co/dnaY7SXzJc $LPCN @vanjohn10 #biotech https://t.co/LJ3rs65Zzt
September 25th 2017, 12:09pm
VCapital_invest @VCapital_invest
Patent Board Motions Decision a Positive $LPCN @vanjohn10 #biotech https://t.co/pYyQZ62Prj https://t.co/mP0Lv5bT1m
September 25th 2017, 11:09am
jimmiebjorling @jimmiebjorling
Patent Board Motions Decision a Positive $LPCN @vanjohn10 #biotech https://t.co/k2DSLLLGrh https://t.co/jNau44FJSN
September 25th 2017, 11:09am
confcalltran @confcalltran
Lipocine: Men'S Health Franchise Testosterone Replacement Therapy (“Trt”) Women'S Health Preter https://t.co/wcgJV0xXC7 $LPCN
September 25th 2017, 8:09am
WKRBNews @WKRBNews
Lipocine Inc. $LPCN Shares Sold by VHCP Management II LLC https://t.co/s0HjsHLOKO
September 24th 2017, 12:09pm
dailymailtimes @dailymailtimes
Lipocine Inc. $LPCN Shares Sold by VHCP Management II LLC https://t.co/tLICpkE5FO
September 24th 2017, 12:09pm
midetimes @midetimes
Lipocine Inc. $LPCN Shares Sold by VHCP Management II LLC https://t.co/25VxyWDuJX
September 24th 2017, 12:09pm
dailypoliticaln @dailypoliticaln
Lipocine Inc. $LPCN Shares Sold by VHCP Management II LLC https://t.co/6MTV8uA86j
September 24th 2017, 12:09pm
TickerReport @TickerReport
Lipocine Inc. $LPCN Shares Bought by Federated Investors Inc. PA https://t.co/lEixFXAm1M
September 23rd 2017, 5:09am
emq_news @emq_news
Lipocine Inc. $LPCN Shares Bought by Federated Investors Inc. PA https://t.co/5Taa2Yliga
September 23rd 2017, 5:09am
TickerReport @TickerReport
Lipocine Inc. $LPCN Shares Bought by Federated Investors Inc. PA https://t.co/790n2EJ53Q
September 23rd 2017, 5:09am
ZacksSmallCap @ZacksSmallCap
$LPCN Advisory Committee Required and USPTO Issues Motion for Tlando @vanjohn10 https://t.co/2duKVg9Tfn
September 22nd 2017, 4:09pm
FDAadcomm @FDAadcomm
Lipocine says it will have an FDA adcomm for it’s oral testosterone, TLANDO. Date is TBD. PDUFA in Feb $LPCN #BRUDAC https://t.co/h80k9KOmlN
September 21st 2017, 6:09pm
keitrader @keitrader
RT @SolarMelt: $LPCN Improvements over current treatments: no BlackBox warning, no more messy gels, no painful injections, no more risk of…
September 21st 2017, 5:09pm
keitrader @keitrader
RT @SolarMelt: $LPCN TLANDO appears poised to dominate a $2B US market, but IP issues remain.
September 21st 2017, 5:09pm
BiotechPhD @BiotechPhD
Hey dummy - Are you still losing money in the stock market? $lpcn https://t.co/x1pkgGmOTQ
September 21st 2017, 1:09pm
LifeSciAdvisors @LifeSciAdvisors
Lipocine $LPCN: Announces Motions Decision by USPTO in Interference Against Clarus https://t.co/NtwGcY60WW
September 21st 2017, 11:09am
7LadyQ @7LadyQ
$LPCN PTAB ruling bolsters Lipocine's position in patent dispute with Clarus Therapeutics; shares ahead 2%
September 21st 2017, 11:09am
MarketCurrents @MarketCurrents
PTAB ruling bolsters Lipocine's position in patent dispute with Clarus Therapeutics; shares ahead 2% https://t.co/qvS92a8JKc $LPCN
September 21st 2017, 10:09am
SEEKINGALPHA_FS @SEEKINGALPHA_FS
PTAB ruling bolsters Lipocine's position in patent dispute with Clarus Therapeutics; shares ahead 2% https://t.co/QXrkmIznr9 $LPCN
September 21st 2017, 10:09am
Briefingcom @Briefingcom
$LPCN: Lipocine announces motions decision by USPTO in interference against Clarus; the PTAB granted Lipocine’s... https://t.co/2zJ6euvd3G
September 21st 2017, 10:09am
vanjohn10 @vanjohn10
$LPCN announces motions decision by USPTO in interference against Clarus. https://t.co/OdVope5VEB
September 21st 2017, 9:09am
SolarMelt @SolarMelt
$LPCN TLANDO appears poised to dominate a $2B US market, but IP issues remain.
September 21st 2017, 9:09am
SolarMelt @SolarMelt
$LPCN Improvements over current treatments: no BlackBox warning, no more messy gels, no painful injections, no more risk of transference.
September 21st 2017, 9:09am
SolarMelt @SolarMelt
$LPCN An Advisory Committee will review TLANDO, aka LPCN-1021, for Hypogonadism sometime before the PDUFA date of FEB 8th, 2018.
September 21st 2017, 9:09am
Mahmissa @Mahmissa
RT @confcalltran: Lipocine Announces Motions Decision By Uspto In Interference Against Clarus https://t.co/qC1RZFRVgy $LPCN
September 21st 2017, 9:09am
ProTradersNews @ProTradersNews
$LPCN: Lipocine Announces Motions Decision by USPTO in Interference …: https://t.co/RoAui4MzaC
September 21st 2017, 8:09am
StockTexts @StockTexts
$LPCN Lipocine Announces Motions Decision by USPTO in Interference Against Clarus Nasdaq:LPCN https://t.co/DvjvStrSyB
September 21st 2017, 8:09am
confcalltran @confcalltran
Lipocine Announces Motions Decision By Uspto In Interference Against Clarus https://t.co/qC1RZFRVgy $LPCN
September 21st 2017, 8:09am
stockboardinc @stockboardinc
$LPCN Lipocine Announces Motions Decision by USPTO in Interference Against Clarus... - https://t.co/BrT1hfnyj5
September 21st 2017, 8:09am
stocknewsdotcom @stocknewsdotcom
$LPCN Announces motions decision by USPTO in interference against Clarus; the PTAB granted Lipocine’s motion to … https://t.co/0mcTMmFnJD
September 21st 2017, 8:09am
GNWLive @GNWLive
Lipocine Announces Motions Decision by USPTO in Interference Against Clarus $LPCN https://t.co/O3CQRsBlgY
September 21st 2017, 8:09am
marketexclusive @marketexclusive
LIPOCINE INC. (NASDAQ:LPCN) Files An 8-K Financial Statements and Exhibits https://t.co/KrTt3ECDuh $LPCN
September 20th 2017, 8:09pm
MaisaCorp @MaisaCorp
$LPCN said FDA Panel meeting date has not been set but will occur prior to the prescription drug user fee act goal date of Feb. 8, 2018
September 20th 2017, 3:09pm
StockNewsNow @StockNewsNow
$LPCN Lipocine Announces FDA Advisory Committee Meeting for TLANDO™ https://t.co/bmnFh7fhFK
September 20th 2017, 1:09pm
SEEKINGALPHA_FS @SEEKINGALPHA_FS
FDA advisory committee to review Lipocine's application for TRT candidate TLANDO; shares up 2% https://t.co/98aTZlFngo $LPCN
September 20th 2017, 12:09pm
MarketCurrents @MarketCurrents
FDA advisory committee to review Lipocine's application for TRT candidate TLANDO; shares up 2% https://t.co/sLBMZMwaWW $LPCN
September 20th 2017, 12:09pm
LifeSciAdvisors @LifeSciAdvisors
Lipocine $LPCN: Announces FDA Advisory Committee Meeting for TLANDO™ https://t.co/NtwGcY60WW
September 20th 2017, 10:09am
Briefingcom @Briefingcom
$LPCN: Lipocine announces that the Bone, Reproductive and Urologic Drugs Advisory Committee of the FDA plans to... https://t.co/f7I2zk00ou
September 20th 2017, 10:09am
tsilver_apex @tsilver_apex
@BioStocks Quick correction: $LPCN
September 20th 2017, 8:09am
NewsToDesk @NewsToDesk
$LPCN: Lipocine Announces FDA Advisory Committee Meeting for TLANDO™: https://t.co/YQnkFjDnxQ
September 20th 2017, 8:09am
bkfViking123 @bkfViking123
$lpcn risk reward is huge ... end game ..... long
September 20th 2017, 8:09am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.